Tesla and CureVac filed a joint patent on the technology. In August, Musk reviewed the project with Curevac while in Germany. By 2017, CureVac had received...
29 KB (2,394 words) - 19:29, 12 September 2024
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness...
19 KB (1,581 words) - 06:57, 24 September 2024
including Deutsche Post, Deutsche Telekom, Commerzbank, Lufthansa, and CureVac. In 2013, KfW agreed to help establish a Portuguese financial institution...
15 KB (1,480 words) - 20:57, 4 August 2024
concerning the use of RNA and is a founder of the German biotechnology company CureVac. He created the initial technology used in RNA vaccines and has reportedly...
14 KB (1,504 words) - 05:01, 7 September 2024
Oxford-AstraZeneca at €1.78; Johnson & Johnson at $8.50, Sanofi-GSK at €7.56, CureVac at €10, and Moderna at $18. In the same month, Israel ordered 8 million...
41 KB (3,732 words) - 00:41, 14 October 2024
additional companies such as Viacyte (part of Vertex), Nkarta, Capsida, Curevac, and others. CRISPR Therapeutics has drugs approved and in development...
11 KB (918 words) - 14:13, 19 April 2024
German biotechnology company CureVac to jointly develop a product incorporating Acuitas' LNP technology with CureVac's mRNA materials. The encapsulated...
25 KB (2,045 words) - 06:35, 23 September 2024
Behring (subsidiary of CSL; 1904– ) CSPC (1992- ) CSPC Zhongrun (1989– ) CureVac (2000– ) Cyclacel (1997– ) Cytokinetics (1997– ) CytRx (1985– ) Daewoong...
34 KB (2,175 words) - 05:58, 20 September 2024
the Pfizer–BioNTech and Moderna vaccines. The CVnCoV RNA vaccine from CureVac failed in clinical trials. Severe allergic reactions are rare. In December...
202 KB (22,928 words) - 23:44, 14 October 2024
(€955 million). In July 2020, GSK acquired a 10% stake in German biotech company CureVac. In March 2018, GSK announced that it has reached an agreement with Novartis...
135 KB (12,153 words) - 13:13, 1 October 2024